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Brain cells expend large amounts of energy sequestering calcium (Ca2+), while loss of
Ca2+ compartmentalization leads to cell damage or death. Upon cell entry, glucose is
converted to glucose-6-phosphate (G6P), a parent substrate to several metabolic major
pathways, including glycolysis. In several tissues, G6P alters the ability of the endoplasmic
reticulum (ER) to sequester Ca2+. This led to the hypothesis that G6P regulates Ca2+
accumulation by acting as an endogenous ligand for sarco-endoplasmic reticulum calcium
ATPase (SERCA).WholebrainERmicrosomeswerepooledfromadultmaleSprague-Dawley
rats. Using radio-isotopic assays, 45Ca2+ accumulation was quantified following incubation
with increasing amounts of G6P, in the presence or absence of thapsigargin, a potent
SERCA inhibitor. To qualitatively assess SERCA activity, the simultaneous release of
inorganic phosphate (Pi) coupled with Ca2+ accumulation was quantified. Addition of G6P
significantly and decreased Ca2+ accumulation in a dose-dependent fashion (1–10mM).
The reduction in Ca2+ accumulation was not significantly different that seen with addition
of thapsigargin. Addition of glucose-1-phosphate or fructose-6-phosphate, or other glucose
metabolic pathway intermediates, had no effect on Ca2+ accumulation. Further, the release
ofPi wasmarkedly decreased, indicatingG6P-mediatedSERCA inhibition as the responsible
mechanism for reduced Ca2+ uptake. Simultaneous addition of thapsigargin and G6P did
decrease inorganic phosphate in comparison to either treatment alone, which suggests
that the two treatments have different mechanisms of action. Therefore, G6P may be
a novel, endogenous regulator of SERCA activity. Additionally, pathological conditions
observed during disease states that disrupt glucose homeostasis, may be attributable to
Ca2+ dystasis caused by altered G6P regulation of SERCA activity.
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INTRODUCTION
Cell function and survival relies on precisely regulated and dis-
tributed calcium (Ca2+) stores. To prevent unregulated Ca2+-
dependent activity, cells sequester Ca2+ behind biomembranes
in organellar compartments maintaining total cellular Ca2+ con-
centration in the low millimolar range. Most Ca2+ is sequestered
within organelles, including the endoplasmic reticulum (ER),
Golgi, mitochondria, and nucleus (Carafoli, 1987; Dong et al.,
2006; Vandecaetsbeek et al., 2011), while resting cytosolic Ca2+
concentration ([Ca2+]cyt) is maintained in the low nanomolar
range (Usachev et al., 1995).
Compartmentalizing Ca2+ requires constant cellular energy
expenditure, and glucose energy metabolism requires Ca2+-
dependent enzymes. These two processes are thus interdependent.
Structurally, soluble glycolytic enzymes in erythrocytes co-localize
with membrane-bound ATPase transporters, an organization that
provides readily availableATP for transport activity (Schrier, 1966;
Jeremy et al., 1992; Nakamura et al., 1993; Xu et al., 1995; Xu and
Becker, 1998). In myocardium, glycolytic enzymes are anchored
next to sarco-endoplasmic reticulum calcium ATPase (SERCA),
allowing direct energy support for the transport of Ca2+ from the
myoplasm into the ER lumen (Xu et al., 1995), while inhibition of
glycolysis interrupts Ca2+ transport by decreasingATP availability
(Paul et al., 1989). In pancreatic beta cells, exposure to elevated
extracellular glucose resulted in a transient increase followed by
an decrease in [Ca2+]cyt , possibly due to influx of extracellular
Ca2+ via capacitative entry followed by organellar uptake (Gylfe,
1988). However, the mechanism by which alterations in glucose
metabolism result in altered Ca2+ homeostasis has not been
fully determined, although current data suggest a more rapid,
directly involved process than simply changes in energy supplies
with downstream Ca2+ ramifications. Over the past two decades,
research efforts have begun to focus on glucose-6-phosphate
(G6P), a key metabolite of glucose, as the link between glucose
metabolism and Ca2+ homeostasis.
Once glucose enters cells, it is rapidly phosphorylated to pro-
duce G6P, which “traps” the charged metabolite within the cell.
Depending on tissue type and needs of the cell, this “hub”
metabolite can then enter one of three major metabolic path-
ways: glycolysis, the pentose phosphate shunt or glycogenesis.
One of the first investigations into the effect of G6P on Ca2+
accumulation used rat liver ER microsomes (Benedetti et al.,
1985). In comparison to oxalate, addition of G6P, which can act
as an anion, significantly reduced Ca2+ accumulation. Further
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experiments comparing G6P-mediated changes in Ca2+ accumu-
lation in comparison to those observed by addition of oxalate
alone were not performed, which makes interpretation of the
results difficult. In contrast, Chen et al. (1998) reported increased
SR/ER microsomal Ca2+ accumulation in whole rat brain, liver,
and heart microsomal preparations after an extremely short time
period of G6P incubation (Chen et al., 1998). No mechanism was
asserted, and, unfortunately, the parameters of these fluorometric
and light scattering assays produced somewhat ambiguous results
and made speculation regarding possible mechanisms of G6P-
mediated alterations in Ca2+ accumulation difficult. Therefore,
while a thorough review of the current literature supports the
hypothesis that G6P regulates Ca2+ accumulation in SR/ER, the
precise nature of the effect remains unknown.
The volume of scientific literature devoted singularly to glu-
cose energy metabolism and Ca2+ homeostasis under physio-
logical and pathological conditions is impressive. Surprisingly,
however, there have been few investigations into mechanisms
by which these two interdependent physiological pathways are
coupled or linked pathophysiologically. Attempts to mechanis-
tically link glucose metabolism with Ca2+ homeostasis have led
to promising advances that could open major avenues into the
understanding of numerous diseases. Characterizing the exact
mechanism by which G6P directly regulates Ca2+ homeostasis is
fundamental in this regard.
MATERIALS ANDMETHODS
MATERIALS
All chemicals and reagents were laboratory grade, and purchased
from Sigma-Aldrich chemical company (St. Louis, MO) unless
otherwise stated. The vacuum manifold and 96-well filter plates
were fromMillipore (Bedford, MA).
ANIMALS
Male Sprague-Dawley (SD) rats (Taconic) aged 12–16 weeks were
used for all experiments. Animal procedures were approved by the
Uniformed Services University of the Health Sciences Institution
for Animal Care and Use Committee in accordance with inter-
national guidelines on the ethical use of animals. Rats received ad
libitum access to standard rodent chow (Harlan Teklad, Frederick,
MD) and maintained on a 12 h light/dark cycle until euthanized.
PREPARATION OF MICROSOMES
Whole rat brain microsomes were prepared by differential den-
sity centrifugation as previously described (Verma et al., 1992).
Briefly, rats were sedated by CO2 narcosis to absence of toe-pinch
and decapitated. Brains were rapidly removed and immediately
placed on a glass plate on ice while minced in ice-cold homog-
enization buffer (250mM sucrose, 20mM HEPES, pH 7.35)
supplemented with 100µM EDTA and a protease inhibitor cock-
tail (Sigma, St. Louis, MO) that contained 4-(2-aminoethyl)
benzenesulfonyl fluoride (AEBSF), pepstatin A, E-64, bestatin,
leupeptin, and aprotinin. Eight minced brains per microsomal
preparation were pooled and homogenized in 10 volumes of ice-
cold buffer using a motor-driven glass/Teflon homogenizer. The
following was performed at 4◦C. The chilled homogenate was
centrifuged at 1000 × g for 10min and the supernatant decanted
and centrifuged at 10,000 × g for 15min. The supernatant was
retained for subsequent ultracentrifugation at 100,000 × g for
1 h. The supernatant was discarded and the pellet rinsed twice
with ice-cold homogenization buffer to remove all trace of EDTA
and protease inhibitors before resuspending in 2mL of ice-cold
homogenization buffer. Protein quantification was determined
using the BCA method (Pierce Biotech, Rockford, IL) and the
supernatant diluted to a final concentration of 2.5mg/mL of
protein and stored at -70◦C in 1.2mL aliquots until use.
45Ca2+ UPTAKE IN MICROSOMES
The Ca2+ uptake assay is a protocol developed in our lab per-
formed in a 96-well filter microplate format as described pre-
viously with some modifications (Verma et al., 1992; Watson
et al., 2003). To help ensure reproducibility and validity, Ca2+
uptake was studied using buffers prepared in bulk by World
Precision Instruments, Inc. (WPI, Sarasota, FL) that contained
20mM HEPES (pH 7.35), 10mM KCl, 5mM NaN3, 3% (w/v)
polyethylene glycol (mw 10,000), 25mM K2 oxalate, and 50µM
CaCl2. Buffer Ca2+ was EGTA-chelated by WPI from 50µM
total to desired free concentrations. Unless otherwise stated, free
Ca2+ concentration used was 300 nM. All reactions were initiated
by the addition of ATP. Vacuum filtration halted reactions, and
microplate filters were washed twice with ice-cold wash buffer
(100mM KCl, 10mM K2 oxalate, 3% (w/v) PEG, 5mM MgCl2,
10mM HEPES-KOH (pH 7.3), and 2mM EGTA). Unless oth-
erwise indicated, all reactions proceeded at 37◦C for 60min.
Treatment with the Ca2+ ionophore A23187 was used to deter-
mine non-specific activity. Scintillation fluid was added to filter
plate wells and amount of 45Ca2+ per well-measured using a
1450 Microbeta Trilux 2 (Perkin Elmer, San Jose, CA). Once col-
lected, the data for each treatment was normalized to the control
outcome.
45Ca2+ UPTAKE IN FRESH FROZEN SECTIONS
Radiotracer 45Ca2+ uptake was also studied autoradiographically
in fresh frozen brain sections. Thawed sections from −70◦C were
incubated in permeabilization buffer (10mM HEPES, pH 7.3,
100mM KCl, 5mM NaN3, 3% (w/v) PEG, 1mM DTT, and
50µM digitonin) for 10min at room temperature (21◦C). The
sections were then transferred to slide mailers containing 12mL
of radiotracer Ca2+ uptake buffer used in the microsomal Ca2+
assays without or with indicated treatments and incubated at
37◦C for 60min. Reactions were halted by placing slides in ice-
cold wash buffer (100mMKCl, 10mMK2 oxalate, 3% (w/v) PEG,
5mM MgCl2, 10mM HEPES-KOH (pH 7.3), and 2mM EGTA)
for two separate 5min rinses. Slides were then air-vacuum dried
before placing in a cassette with beta-particle sensitive film until
developed.
Ca2+ PRE-LOAD AND LEAK ASSAY
Microsomal uptake and release of Ca2+ were measured using
radiotracer 45Ca2+ in uptake assays performed in 96-well filter
plates as described above with modifications. Microsomes were
pre-loaded with 45Ca2+ for 45min, as described above. After
45min of uptake, treatments were added including control (no
treatment), and the assay allowed to continue another 15min.
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Microsomal Ca2+ accumulation was subsequently measured by
vacuum filtration at 60min followed by scintillation counting.
Once again, non-specific background was considered 45Ca2+
measured in the presence of 10µM A23187. Calcium leakage
was defined as 45Ca2+ accumulated in the presence of a SERCA
inhibitor, such as thapsigargin (thapsigargin), subtracted from
control uptake at 60min. Since the addition of a SERCA inhibitor
after 45min of uptake would prevent virtually all further micro-
somal uptake by definition, any decrease in microsomal Ca2+
accumulation compared to control measured at 60min would
be considered leakage via passive or non-stimulated cycling res-
ident ER receptor channels [1,3,4-Inositol-triphosphate receptors
(IP3Rs), or ryanodine receptors (RYRs)].
QUANTIFICATION OF SERCA HYDROLYTIC ACTIVITY
In microsomes, SERCA activity is the primary mechanism for the
hydrolysis of ATP to release Pi. Quantification of Pi release allows
for an indirect measurement of SERCA activity in conditions
which optimize Ca2+ uptake into the ER lumen. A previously
described colorimetric assay (Ekman and Jager, 1993) adapted
from the ammonium molybdate/malachite green method quan-
tified Pi production by SERCA activity. Colorimetric reagent was
prepared by mixing one volume of 10% (w/v) (NH4)6Mo7O24–
4 H2O in 4M HCl with three volumes of 0.2% (w/v) malachite
green in 4M HCl, followed by stirring (30min), then grav-
ity filtration (Whatmann filter paper, pore size six microns,
Millipore, Billerica, MA) to remove large sediment containing
(NH4)6Mo7O24 (ammonium molybdate, added to reagent in
excess) and contaminants. A 1–12 nmol standard curve of potas-
sium phosphate was generated to correlate color development
with Pi concentration.
SERCA activity was determined by measuring Pi release in
eight separate conditions: control, G6P, G1P, and F6P (all at
10mM), in the absence and presence of thapsigargin (1µM).
For each experiment, all treatment conditions were simulta-
neously analyzed in 1.5mL centrifuge tubes containing 440 uL
pre-warmed (37◦C) Ca2+ uptake buffer (see above) supple-
mented with 1mM ouabain and 40µL microsomal preparation
(2.5mg protein/mL) for 10min at 37◦C. The addition of 3mM
Mg2+ and 2mM ATP prepared in Ca2+ uptake buffer (19µL)
initiated SERCA activity. Aliquots (25µL) were collected and
mixed with 775µL ultrapure water and 200µL colorimetric
reagents. After 10min incubation at room temperature, sam-
ples (200µL) were then read (OD660) in a FLUOstar Omega
microplate reader (BMG Labtech, Cary, NC). Since an ATP-
regenerating system was not used, ATP was the limiting factor
in SERCA-mediated Ca2+ uptake, and SERCA hydrolytic activity
was determined after 6min to prevent ATP reduction secondary
to ATPase activity from affecting reproducibility. Each sample was
measured in triplicate and mean activity calculated (nmol phos-
phate released/min/mg soluble protein). SERCA activity for each
treatment was then calculated as the difference between measured
activity in the absence and presence of thapsigargin.
STATISTICAL ANALYSES
Collected data were analyzed via ANOVA using SigmaStat (Systat
Software, Chicago, IL). When normality tests failed, a Kruskal
Wallis ANOVA on Ranks was performed. Significance was based
on two-tailed tests, with p < 0.05. For post hoc comparisons,
Holm–Sidak Tests were used. Data analysis was performed at the
conclusion of the project, after all results were collected. For all
experiments, an “n” value of 5–7 was used, with each single “n”
consisting of eight pooled brains.
RESULTS
GLUCOSE-6-PHOSPHATE SIGNIFICANTLY REDUCED
ENDOPLASMIC RETICULUM CALCIUM ACCUMULATION
In whole rat brain ER microsomes, G6P (10mM) significantly
reduced Ca2+ accumulation when compared to control (0mM),
while two other cytosolic hexose phosphates did not affect
Ca2+ accumulation (Figure 1). Increasing concentrations of G6P
caused a dose-dependent decrease in Ca2+ accumulation in ER
microsomes with the maximum experimental concentration of
G6P (10mM) reducing microsomal Ca2+ accumulation in com-
parison to control. At low concentrations (1.25 and 2.5mM),
reduction did not reach statistical significance. In contrast, two
G6P 6-carbon metabolites from different pathways, glucose-
1-phosphate (glycogenesis) and fructose-6-phosphate (glycol-
ysis), did not affect Ca2+ accumulation (p > 0.05) at any
concentration.
GLUCOSE METABOLITES DID NOT ALTER ENDOPLASMIC
RETICULUM CALCIUM ACCUMULATION
To verify the specificity of the response to G6P, the ER Ca2+
accumulation assay was repeated using nine other metabolites
that are ultimately derived from glucose, or that are intimately
FIGURE 1 | In comparison to other hexose phosphates,
glucose-6-phosphate reduces the accumulation of 45Ca2+
in brain ER microsomes. Addition of glucose-6-phosphate (10mM),
but not glucose-1-phosphate (10mM) or fructose-6-phosphate (10mM),
significantly reduced (p < 0.05) calcium accumulation. Data are
means ± SEM for n = 5. Each microsomal preparation contained
a minimum of eight whole brains pooled together. abMeans
with differing superscripts are significantly different, p < 0.05,
while means that share superscripts are not significantly
different.
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Table 1 | After 60min of incubation, intermediates in glycolysis, the
TCA cycle, and the pentose phosphate shunt did not affect the
accumulation of 45Ca2+.
Substrate Percent of control
GLYCOLYSIS
Glucose 93 ± 6.04
Fructose-1,6-bisphosphate 109 ± 7.27
Pyruvate 110 ± 7.42
TCA CYCLE
Aspartate 93 ± 2.81
Malate 100 ± 2.34
Oxaloacetate 95 ± 6.60
Glutamate 94 ± 6.60
PENTOSE PHOSPHATE SHUNT
Phosphogluconic acid 97 ± 9.76
Gluconolactone 104 ± 6.72
Separate addition of nine different metabolites (10mM, each) involved in three
pathways dependent on G6P demonstrated that none significantly altered
(p > 0.05) the accumulation of calcium. Data are presented as means of percent
of control ± SEM for n = 4. Each microsomal preparation contained a minimum
of eight whole brains pooled together.
involved in glucose metabolism (Table 1). Most interestingly, glu-
cose alone had no effect (p > 0.05) on ER Ca2+ accumulation,
nor did other glycolytic intermediates (fructose-1,6-bisphosphate
and pyruvate). Intermediates of the TCA cycle (aspartate, glu-
tamate, malate, and oxaloacetate) were likewise without effect
(p > 0.05) on ER Ca2+ accumulation. Since G6P can also be used
in the pentose phosphate shunt, phosphoglucolactone, and glu-
conolactone were also tested, with no effect (p > 0.05) on Ca2+
accumulation.
REDUCTION IN CALCIUM ACCUMULATION CAUSED BY
GLUCOSE-6-PHOSPHATE IS NOT REGIONALLY SPECIFIC
Since ER microsomes were prepared from whole brain
homogenates, brain regional variability could not be evalu-
ated. Fresh frozen sections were analyzed autoradiographically to
determine the anatomical regional distribution of G6P-sensitive
pools of ER Ca2+ accumulation (Figure 2). In comparison to
control, G6P and thapsigargin caused generalized reduction
in Ca2+ accumulation in remarkably similar patterns with no
apparent gray matter regional heterogeneity noted. Additionally,
white matter areas also demonstrated reduced accumulation
indicating treatment response is a fundamental mechanism
ubiquitously expressed throughout all brain regions, including
gray and white matter. Rat forebrain treated with low (1mM)
and high (10mM) concentrations of G6P demonstrated a
dose-dependent reduction in Ca2+ accumulation (Figure 2A),
while thapsigargin also reduced Ca2+ accumulation (Figure 2B).
Overall response appeared minimal at 1mM, however, 10mM
G6P markedly and diffusely reduced Ca2+ accumulation
compared to control. Focused examination of the hippocampus
formation demonstrated noticeable decreased Ca2+ accumu-
lation compared to control even at 1mM (Figure 2C). At the
FIGURE 2 | In fresh frozen rat brain sections, glucose-6-phosphate
caused a generalized reduction in the accumulation of 45Ca2+.
Treatment of fresh frozen brain sections with glucose-6-phosphate (10mM)
or thapsigargin (1µM), revealed very similar pattern of generalized
reduction in 45Ca2+ accumulation in gray and white matter. No regional
specificity was observed, as the effect of both treatments appeared to be a
diffuse response. Images are representative of n = 4.
larger, 10mM concentration, G6P reduces Ca2+ accumula-
tion to such an extent the hippocampal formation becomes
unrecognizable.
GLUCOSE-6-PHOSPHATE APPEARS TO REDUCE CALCIUM
ACCUMULATION VIA INHIBITION OF SERCA
Since the pattern of accumulation in sections following G6P
treatment appeared to mimic that seen following thapsigargin-
induced inhibition of SERCA, further experiments examining
G6P and thapsigargin inhibition were performed. Comparison
of Ca2+ accumulation in microsomes was performed, follow-
ing incubation with G6P, thapsigargin, or G6P plus thapsigargin
(Figure 3). Both G6P and thapsigargin significantly reduced (p <
0.05) microsomal Ca2+ accumulation, while simultaneous addi-
tion of G6P and thapsigargin did not further decrease Ca2+
accumulation (p > 0.05).
SERCA is an Mg2+, ATP-dependent enzyme, using energy
yielded from ATP hydrolysis to transport, via conformational
change, cytosolic Ca2+ against its electrochemical gradient into
the ER lumen while releasing ADP and inorganic phosphate
(Pi) into the cytosol (buffer, experimentally). Taking advan-
tage of this enzymatic process allows for indirect quantification
of SERCA activity by colorimetrically quantifying Pi release in
ER microsomal preparations following experimental treatment.
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FIGURE 3 | After 60min of incubation, glucose-6-phosphate reduces
the accumulation of 45Ca2+ in brain ER microsomes. Addition of
glucose-6-phosphate (10mM), thapsigargin (1µM), or the two in
combination significantly reduced (p < 0.05) calcium accumulation.
Individually, glucose-6-phosphate and thapsigargin reduced calcium
accumulation by approximately 50%. When the two treatments were
combined, there was no additive effect. Data are means ± SEM for n = 5.
Each microsomal preparation contained a minimum of eight whole brains
pooled together. abMeans with differing superscripts are significantly
different, p < 0.05, while means that share superscripts are not
significantly different.
Release of Pi was quantified after incubation in four separate con-
ditions: control, 1µM thapsigargin, 10mM G6P, or 1µM thap-
sigargin plus 10mM G6P. Maximal Pi release, which is indicative
of maximal SERCA activity and hence the largest Ca2+ accumu-
lation, was observed in the control condition (Figure 4). A net
decrease in Pi release, indicative of diminished SERCA activity
and thus reduced Ca2+ accumulation was observed following sep-
arate addition of G6P and thapsigargin. While the combination of
G6P and thapsigargin also decreased net Pi release in comparison
to control (p < 0.05), this effect was not additive or synergis-
tic and was, in fact, no different (p > 0.05) from thapsigargin
treatment alone.
While previously it was demonstrated that G6P is the only glu-
cose metabolite having a significant reducing effect on Ca2+ accu-
mulation, the specificity of the inhibitory effect on SERCA activity
was confirmed by comparison to treatment with G1P (10mM)
and F6P (10mM). As before, SERCA activity was reduced (p <
0.05) following the addition of G6P, but neither G1P nor F1P had
an effect (p > 0.05) on Pi release (Figure 5).
Since the original Ca2+ accumulation was measured after
60min of incubation, while Pi release was quantified at 6min
due to the necessary exclusion of ATPase regenerating systems
(described in Methods), Ca2+ accumulation assays were repeated
at 6min to allow for a direct comparison (Figure 6). As with
the 60min assay, thapsigargin alone significantly reduced (p <
0.05)microsomal Ca2+ accumulation, which G6P showed a trend
toward reduced (p < 0.10) Ca2+ accumulation. Interestingly,
when quantified after only 6min of incubation, simultaneous
FIGURE 4 | Glucose-6-phosphate reduces SERCA activity, as quantified
by the release of inorganic phosphate from rat brain ER microsomes,
in comparison to control. Glucose-6-phosphate significantly reduced
(p < 0.05) the release of inorganic phosphate from brain ER microsome
preparations after incubation for 6min. However, the decrease in SERCA
activity was not as great as that observed with the addition of thapsigargin
(1µM), a known potent, irreversible SERCA inhibitor. Treatment by both
glucose-6-phosphate and thapsigargin did not further reduce accumulation
below that of thapsigargin alone. Data are means ± SEM for n = 7.
abcMeans with differing superscripts are significantly different, p < 0.05,
while means that share superscripts are not significantly different.
addition of G6P and thapsigargin additively reduced Ca2+ accu-
mulation (p < 0.05) compared to individual treatment.
GLUCOSE-6-PHOSPHATE DOES NOT CAUSE RELEASE OF
CALCIUM FROM ER POOLS
To investigate the possibility that G6P could be stimulating
release from ER microsomal pools, Ca2+ accumulation pro-
tocols were used to pre-load ER microsomes for 45min with
radio-tracer 45Ca2+ before application of one of three treatments
(G6P, thapsigargin, A23187) for an additional 15min (Figure 7).
Net accumulation at 60min was then compared between treat-
ments. Neither G6P nor thapsigargin, a known potent irreversible
SERCA inhibitor, caused significant Ca2+ release (p > 0.05),
although both treatments markedly decreased the rate of Ca2+
accumulation between 45 and 60 min (Figure 7). In contrast,
the Ca2+ ionophore A23187 caused a rapid, significant release
of Ca2+ with a profile far different from that of G6P and thap-
sigargin, with net ER microsomal Ca2+ concentration at 60min
significantly reduced (p < 0.05) compared to that at 45min.
DISCUSSION
The key finding in this study is G6P dose-dependently reduces
Ca2+ accumulation in rat brain ER. Further, the mechanism of
reduction is via inhibition of SERCA activity and not stimulation
of classical or novel release channels. More specifically, G6P is an
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FIGURE 5 | Glucose-6-phosphate reduces microsomal SERCA
hydrolytic activity, as quantified by decreased release of inorganic
phosphate in comparison to other hexose phosphates tested.
Glucose-6-phosphate (10mM) significantly reduced (p < 0.05) the release
of inorganic phosphate from brain ER microsomes after 6min incubation.
Neither glucose-1-phosphate (10mM) nor fructose-6-phosphate (10mM)
altered phosphate release (p > 0.05) in comparison to control. Data are
means ± SEM for n = 7. abMeans with differing superscripts are
significantly different, p < 0.05, while means that share superscripts are
not significantly different.
endogenous inhibitor of the thapsigargin-sensitive ER Ca2+ pool.
These data suggest G6P, the first product in glucose metabolism,
regulates Ca2+ homeostasis and directly links these two physio-
logical processes. Further, this effect is unique to G6P, as neither
glucose, which is an uncharged or neutral molecule, nor other
phosphohexoses which are anionic compounds alter the ability of
microsomes to sequester Ca2+.
This study is not the first to examine the effects of G6P on
Ca2+ accumulation in isolated microsomes; however, it is the
first to propose a mechanism. Previous studies provided ambigu-
ous data regarding the effect of G6P on Ca2+ accumulation in
microsomes isolated from rat kidney, liver, heart, brain, and per-
meabilized pancreatic islet cells (Benedetti et al., 1985; Wolf et al.,
1986; Fulceri et al., 1990; Chen et al., 1998). A major differ-
ence between our experiments and those mentioned previously is
the predominant presence of a permeable anion in the buffer, in
addition to the anion G6P. The assay buffer used in these exper-
iments included dipotassium oxalate (25mM) to maximize the
accumulation of 45Ca2+ in isolated microsomes. Sequestration
of luminal free Ca2+ by oxalate eliminates negative feedback
inhibition on SERCA activity (Wells and Abercrombie, 1998) and
provides greater sensitivity for quantifying the effects of G6P
(Benedetti et al., 1985). If G6P acted solely as an anion to complex
with intra-luminal Ca2+ in the radiotracer uptake microsomal
assay, then accumulation in ER lumens during incubation would
be expected to increase compared to control (absence of G6P).
However, 10mM G6P causes dramatic reductions in microso-
mal Ca2+ accumulation (∼60% reduction compared to control
in whole rat brain microsomes) even in the presence of a potent
FIGURE 6 | After 6min of incubation, glucose-6-phosphate
demonstrated a trend toward reduced accumulation of 45Ca2+ in brain
ER microsomes. Addition of glucose-6-phosphate (10mM) demonstrated a
trend toward reduced accumulation of calcium (p < 0.10), while
thapsigargin (1µM) reduced ER Ca2+ accumulation (p < 0.05). When
combined, the treatments additively reduced ER Ca2+ accumulation
(p < 0.05) in comparison to control. Data are means ± SEM for n = 5. Each
microsomal preparation contained a minimum of eight whole brains pooled
together. abcMeans with differing superscripts are significantly different,
p < 0.05, while means that share superscripts are not significantly different.
FIGURE 7 | Neither glucose-6-phosphate nor thapsigargin cause
release of 45Ca2+ from rat brain ER microsomes. After pre-loading ER
microsomes with radiotracer 45Ca2+ uptake for 45min,
glucose-6-phosphate (10mM), thapsigargin (1µM), or the calcium
ionophore A23187 (10µM) treatment was added for 15min. Only A23187
caused release of 45Ca2+ from the rat brain microsomes when measured
by beta counter. Both glucose-6-phosphate and thapsigargin reduced the
rate of accumulation, but did not cause release. Data are means ± SEM for
n = 7.
intraluminal Ca2+ complexing anion (oxalate). The advantage of
using ER microsomal preparations, in combination with fresh
frozen slices for comparison, is that the glycolytic enzymes and
mitochondrial function have been removed or extinguished.
Therefore, G6P cannot simply be used for the provision of energy
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to the SERCA, since the cellular machinery needed for ATP pro-
duction is absent. Benedetti et al. (1985) reported that G6P
significantly reduced Ca2+ accumulation in ERmicrosomes when
compared to assay buffers containing oxalate (Benedetti et al.,
1985). However, G6P increased intraluminal Ca2+ in the absence
of buffering anions. Inclusion of buffering anions in Ca2+ accu-
mulation assays, which mimics in vivo conditions, provide the
necessary sensitivity to elucidate mechanism(s) by which G6P
regulates Ca2+ uptake into the ER. Future work utilizing an in
vivo model, with a full complement of anions, cations, enzymes,
and transporters, is required to confirm the exact mechanism of
G6P-mediated changes in ER Ca2+ homeostasis under physiolog-
ical conditions.
In nearly every experiment conducted G6P and thapsigargin
resulted in identical outcomes, notably in experiments designed
to test the effects of G6P on SERCA. SERCA is a Ca2+ ATPase
that transports Ca2+, while producing ADP and Pi from ATP.
Thapsigargin reduces Ca2+ accumulation by irreversibly bind-
ing to the SERCA and reducing ATPase activity, thus limiting the
production of ADP + Pi (Thastrup et al., 1990; Lytton et al., 1991;
Caspersen and Treiman, 1995; Poulsen et al., 1995). Therefore,
to investigate if G6P similarly inhibits SERCA activity, Pi release
from microsomes was quantified following treatment with G6P
and thapsigargin, individually and combined. As with other mea-
sures, G6P and thapsigargin had an individual effect (reduced
Pi hydrolysis by inhibiting SERCA activity), but did not have an
additive/synergistic effect. However, there was a minor difference
in the amount of Pi released, as well as in the Ca2+ accumula-
tion when measured at 6 and 60min, the only experiments with
this minor discrepancy between the two treatments. However, it
should be noted that thapsigargin binds irreversibly to SERCA. In
contrast, G6P, an endogenous and ubiquitous metabolite, would
not be expected to bind SERCA in an irreversible fashion due to
the negative bioenergetic consequences and tumorigenic poten-
tial. Quite likely, this difference in irreversible and reversible
binding, between thapsigargin and G6P, respectively, explains
these minor discrepancies. Comparisons of Ca2+ accumulation in
fresh frozen brain sections following incubation with thapsigar-
gin or G6P revealed an identical diffuse, regionally non-specific
reduction in Ca2+ accumulation. In contrast, previously pub-
lished data examining the effects of IP3 and RYR antagonists
demonstrate a regionally specific, and complementary, pattern of
reduced Ca2+ accumulation (Verma et al., 1990a,b, 1992).
These results, while convincing evidence that G6P and thapsi-
gargin reduce ER Ca2+ accumulation via a similar mechanism(s)
(i.e., inhibition of SERCA), were not conclusive. Therefore,
a Ca2+ release assay was performed using thapsigargin and
G6P. Microsomes were loaded for 45min with Ca2+, then G6P
and thapsigargin separately or together. A23187, an ionophore
that causes rapid near emptying of Ca2+ from microsomes to
equilibrium with the buffer was used to measure non-specific
background. While the ionophore (A23187) caused rapid near
total emptying of the microsomes, both G6P and thapsigargin
appeared to decrease the rate of uptake and not causing a direct
release of accumulated Ca2+. ER Ca2+ accumulation is a contin-
uing balance between SERCA-mediated uptake and release via
Ca2+ channels and leak pathways. By reducing SERCA activ-
ity without altering release mechanisms, G6P (and thapsigargin)
lower the setpoint of ER Ca2+ content by reducing accumulation.
A demonstrable link between glucose metabolism and regu-
lation of Ca2+ sequestration mechanism will influence not just
understanding of basic cellular physiology, but may have major
implications for the study of a variety of clinically relevant neu-
ropathologies. For example, diabetes and hyperglycemia are well-
documented to cause significantly worse outcome for patients
who suffer traumatic brain injury or stroke. Further, many of
the clinical manifestations of these neuropathologies are strongly
associated with altered Ca2+ homeostasis. However, the underly-
ing mechanism(s) of this relationship has not been determined.
By offering a direct, mechanistic link between G6P and disrup-
tions in Ca2+ accumulation commonly observed in brain injury,
such as after stroke or traumatic brain injury, these results sug-
gest new approaches to large scale, old problems with important
clinical ramifications.
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